X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

Vienna Airport and Lufthansa Cargo launch pharma cooperation

Content Team by Content Team
10th May 2022
in Packaging & Logistic, Press Statements
Vienna Airport and Lufthansa Cargo launch pharma cooperation

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The Vienna Airport Pharma Handling Center (VPHC) at Vienna Airport now also handles pharma freight for Lufthansa Cargo. As part of a cooperation between the Lufthansa Group’s cargo subsidiary and Vienna Airport, the handling of all pharma cargo transported on board Austrian Airlines aircraft to or from Vienna Airport will take place at the VPHC from now on. With the VPHC, Vienna Airport operates its own GDP-certified competence center for handling temperature-sensitive air cargo without interrupting the cold chain. The VPHC will further strengthen Vienna Airport’s role as a pharma hub for Central and Eastern Europe with Lufthansa Cargo’s intercontinental network. Freight volumes here have grown significantly in recent years.

Lufthansa Cargo, the Group subsidiary responsible for freight in the Lufthansa Group, is also responsible for the cargo business of Austrian Airlines. On board its passenger aircraft, the Austrian flag carrier also distributes transport goods in an extensive intercontinental network as belly cargo, including pharmaceuticals, vaccines and other temperature-sensitive goods.

The cooperation further establishes Vienna Airport as a strong pharma hub for Central and Eastern Europe. Austria’s most important international airport has significantly increased its tonnages in this area. The airport’s own pharma handling center handled around 15 percent more goods in 2021 than in 2020, with growth of more than 66 percent compared to the pre-crisis year of 2019. In addition to ongoing uncertainties of ground-based global supply chains, the internationalization of pharmaceutical productions also continues to drive this trend.

By linking the intercontinental air cargo capacities of Austrian Airlines to the capabilities of the VPHC, Vienna Airport is well prepared for further growth in this sector. State-of-the-art facilities for handling and storing temperature-sensitive pharmaceuticals and GDP certification ensure optimal processes at the VPHC, handled by a specialized pharma team and monitored by comprehensive temperature control systems.

Two large refrigerated warehouses offer storage facilities for temperatures ranging from 2 to 8 degrees Celsius (150 square meters) and 15 to 25 degrees (1600 square meters). Mobile refrigeration equipment also provides a seamless link between the air and land sides for temperature-sensitive products. Regular and closely timed road feeder services at Vienna Airport also enable fast distribution via the European road network. Thanks to the geographically advantageous positions in Europe, pharma shipments from Vienna can reach 23 countries within 36 hours.

“In the field of life-saving and temperature-sensitive pharma logistics, Lufthansa Cargo provides the fastest possible and most secure handling and deliveries worldwide. Essential for this are the highest quality standards, seamless cold chains and documentation as well as customized solutions for each customer. With the Vienna Pharma Handling Center, we have gained an important cooperation partner in order to be able to offer our high standards for pharma airfreight at Vienna Airport,” says Theresa Schlederer, Director Sales & Handling Austria at Lufthansa Cargo AG.

“As a hub also for medical goods, our Vienna Airport Pharma Handling Center proved its crisis safety and reliability during the Corona period. Even spontaneous charter flights with short times to prepare but high tonnage were handled quickly and smoothly at all times. The fact that Lufthansa Cargo, one of the world’s largest air freight companies, has decided to have its pharmaceutical shipments handled by us is confirmation of our high quality and further strengthens Vienna Airport as a pharma hub for Central and Eastern Europe”, says Michael Zach, Vice President Sales & Finance, Ground Handling & Cargo Operations at Vienna Airport.

About Vienna International Airport:

With its geographically well-situated location in Europe, Vienna Airport has established itself as an important global cargo hub for Central and Eastern Europe. Especially for intercontinental transports, Vienna Airport is serving leading cargo airlines. A 24-hour operational readiness offers fast turnaround times. For air cargo, 10 category F aircraft parking positions (Boeing 747-8, Antonov 124) are available in the close vicinity of the handling facilities. The airport is strongly established in the European network of Road Feeder Services. The most important consumer and economic centers in Central and Eastern Europe are reached within 24 or 48 hours. Flughafen Wien AG, the Vienna stock exchange listed operating company, is one of the largest employers in its region with more than 5,400 employees.

 

Previous Post

In DELIVER Phase III Study, Farxiga Achieved Primary Outcome

Next Post

Boosters For COVID-19 Considerably Vital Than In The Past

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
Future Trends Shaping
Packaging & Logistic

Future Trends Shaping Pharma Supply Chain and Logistics

30th July 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Next Post
Amyris and Immunitybio Complete Joint Venture for Next Generation Covid-19 RNA Vaccine

Boosters For COVID-19 Considerably Vital Than In The Past

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In